Signaling Pathways
-
A8808 ME0328Target: PARPSummary: PARP inhibitor,potent and selective
-
A8809 VorapaxarTarget: Protease-Activated ReceptorsSummary: PAR-1 antagonist,potent and orally active
-
A8812 PD173955Target: Bcr-Abl|SrcSummary: Dual Src/Abl kinase inhibitor, ATP-competitive,
-
A8813 NSC697923Target: Ub-conjugating enzyme (E2) complexSummary: Inhibitor of E2 complex Ubc13-Uev1A,cell permeable and selective
-
A8814 NH1251 CitationTarget: eEF-2Summary: Selective eEF-2 kinase inhibitor
-
B3021 AtglistatinTarget: ATGLSummary: ATGL inhibitor, potent and selective
-
B3041 BTB06584Target: F1 Fo-ATPaseSummary: F1F0 ATP synthases
-
B3058 CK-6361 CitationTarget: Arp2/3 complexSummary: Arp2/3 complex inhibitor
-
B3061 CRT0044876Target: AP endonucleasesSummary: APE1 inhibitor, potent and selective
-
B3179 PTC-209Target: BMI-1Summary: Bmi-1 inhibitor,cell-permeable and small-molecule